Following an investigation prompted by a complaint from Laboratories Quelab, Revenue Canada has found evidence of bacterial culture media dumping from the USA and the UK. The enquiry showed a dumping margin of 37%, the Toronto Globe and Mail reports.
The Canadian International Trade Tribunal is expected to decide by the end of this month whether the dumping of these products is injuring Canadian production, and whether antidumping duties, imposed on imports since January 31, should remain in force.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze